Atlas Trials

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Clinical trial NCT02333188 · COMPLETED

Trial details

NCT number
NCT02333188
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder CarcinomaGastric AdenocarcinomaMalignant Gastrointestinal NeoplasmMetastatic Pancreatic AdenocarcinomaPancreatic AdenocarcinomaStage III Ampulla of Vater CancerStage III Pancreatic CancerStage IIIA Gallbladder CancerStage IIIA Gastric CancerStage IIIB Gallbladder Cancer
Start date
2014-12-01
Primary completion
2017-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.